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employees.  The South African National Departments of Health 
and Social Development and the Gauteng Department of Health 
and the Employees Wellness Program (EWP) also provided 
important support.
This project was funded by the Foreign Assistance Agencies 
of Australia (AusAID), the UK (DFID), and the United States 
of America (USAID), and by the United Nations Development 
Programme (UNDP) of South Africa. Technical assistance was 
provided by the Joint Economics AIDS and Poverty Programme 
(JEAPP), an affiliate of the African Asian Society (AAS).
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Carcinoma of the cervix is the commonest genital malignancy 
afflicting women in the developing world. An estimated 190 
000 women die each year as a result of cervical cancer, with 
80% of these deaths occurring in the developing world.1 
Rates are highest in central America, sub-Saharan Africa and 
Melanesia, making it one of the most important reproductive 
health problems of public health importance in these regions. 
Cervical cancer is preventable by instituting cervical cytological 
screening and treatment of early lesions. In countries where 
screening quality and coverage have been high, Papanicolaou 
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Objective. To establish the relationship between HIV infection 
and cervical dysplasia in young women in rural South  
Methods. This cross-sectional study was conducted at 
a primary health care clinic in Vulindlela, KwaZulu-
Natal. Standardised questionnaires were used to collect 
sociodemographic and clinical presentation data from 
women attending family planning and other reproductive 
health services.  Pap smears were done using standard 
methods.  Pap smear data were linked to HIV serostatus. 
Results. Four hundred and sixty-six women were included 
in the study. The median age was 24.3 years (range 15 - 55 
years), and 80% were younger than 30 years. The HIV preva- 
lence rate was 24.5% (95% confidence interval: 20.7 - 28.7%) 
and the prevalence of abnormal Pap smears was 16.9 - 6.4% 
ASCUS (atypical squamous cells of undetermined signifi-
cance), 9.2% LGSIL (low-grade squamous intraepithelial 
lesions), and 1.3% HGSIL (high-grade squamous  intraepithe 
lial lesions). The association between HIV seropositivity and 
abnormal Pap results was statistically significant (p < 0.05).    
Conclusion. There is a need for more data on cervical changes 
in HIV co-infected women and for review of guidelines 
on selective Pap smear screening in high HIV prevalence 
settings such as sub-Saharan Africa and where access to 
antiretroviral treatment remains limited.
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(Pap) screening efforts have reduced invasive cervical cancer 
incidence by about 70 - 90%.2  
High costs, lack of awareness and absence of adequate health 
infrastructure have prevented most low-resource countries from 
instituting population-wide Pap smear screening programmes. 
Only 5% of women in developing countries undergo cervical 
cancer screening compared with 40 - 50% in the developed 
world.3 Selective cervical cancer screening of women above 30 
years of age at least once in their lifetime has been suggested 
as an alternative Pap smear screening strategy in sub-Saharan 
Africa and other low-resource regions.4,5  
Several studies6-8 have found the prevalence of squamous 
intra-epithelial lesions (SILs) among HIV-positive women to 
be 31 - 63%. Further, the prevalence and degree of dysplasia 
increases with advancing levels of immunosuppression.9,10 The 
burden of HIV infection in sub-Saharan Africa among young 
women under the age of 30 years is increasing.11 While some 
clinicians working in Africa12,13 have expressed concern about 
younger age of cervical cancer presentation, little empirical data 
exist as to the reason for this and whether it is linked with the 
increasing burden of HIV infection in this region. 
The purpose of this study was to assess the relationship 
between Pap smear findings and HIV status in young women 
utilising family planning services in a high HIV prevalence set-
ting in rural South Africa.
Subjects and methods
This cross-sectional study was conducted between November 
2003 and April 2005 among young women utilising family plan-
ning services at the Mafakatini Clinic, Vulindlela district.   
Vulindlela is a rural district in the KwaZulu-Natal midlands, 
about 150 km west of Durban, with approximately 400 000 
residents. The Mafakatini Primary Health Care Clinic is one 
of seven such clinics providing comprehensive primary care 
services to this rural community. 
All women who presented to the clinic during the study pe-
riod for family planning and other reproductive health services 
and who consented to participation in the study were included.  
Sociodemographic and clinical variables including age, marital 
status, parity and sexual history (number of sexual partners) 
were collected after obtaining informed consent. 
A specimen from the cervix was obtained from each partici-
pant using the Ayre’s spatula. The specimen was smeared on 
a slide and fixed using Cytofix according to the conventional 
standard cytological screening procedure. Specimens were 
examined at the regional Department of Health cytopathology 
laboratories. The 1988 Bethesda II classification was used for 
reporting the Pap smear results.
 This study was reviewed and approved by the Nelson R 
Mandela School of Medicine Research Ethics Committee and 
permission to undertake this study was obtained from the 
KwaZulu-Natal Department of Health. Syndromic manage-
ment of sexually transmitted infections (STIs) was provided in 
accordance with the South African Department of Health guide-
lines.14 HIV-positive patients with indications for antiretroviral 
treatment were enrolled into the Centre for AIDS Programme of 
Research in South Africa (CAPRISA) Treatment Project. Patients 
with abnormal Pap smears were referred for further manage-
ment to the tertiary referral hospital for this district.  
Data were managed in Excel and analysed using the SPSS 
11.5 statistical package. 
Results
Sociodemographic characteristics
Of the 479 participants eligible for this study, 13 women 
consented to the Pap smear but refused HIV testing and were 
excluded from the analysis. The mean age of the 466 women 
included in this analysis was 24.3 years (standard deviation 
(SD) 7.0, range 15 - 55 years).  Most of the participants (76.0%) 
were single but had a stable sexual partner, 11.2% were single 
without a sexual partner, 7.3% were married and 4.9% were 
widowed. 
Most participants (52.2%) had completed high school, 43.1% 
were secondary school students, 4.3% had only completed 
primary school, and 0.4% had college education. 
Sexual behaviour, parity, contraception and condom 
use
Information was obtained on the number of sexual partners in 
the previous 6 months; 56.2% of participants reported hav-
ing only 1 partner, 12.4% reported having 3 partners and the 
remainder reported 2 to 6 partners. 
Parity of participants ranged from 1 to 7; 31.5% of partici-
pants were nulliparous and 47.7% were para 1. Depo-Provera 
injectable contraceptive was the most commonly used family-
planning method (60.1%), while 6.2% used combined hormonal 
pills for birth control, none of the participants used an intra-
uterine device or surgical sterilisation methods of contracep-
tion, 8.4% were not on any form of contraception, and 25.3% 
reported use of male condoms. 
HIV status and Pap smear results
Data on Pap smear results and HIV status are presented in 
Table I. The frequency of abnormal Pap smears was 16.9% 
(79/466).  LGSIL (low-grade squamous intraepithelial lesions) 
were the most common abnormality identified (9.2%), and 1.3% 
of the participants had HGSILs (high-grade squamous intraepi-
thelial lesions).  HIV status was not known for 13 participants. 
The HIV prevalence in this cohort was 24.5%.  There was a 
statistically significant association between HIV infection and 
abnormal Pap smear findings (10.3% among HIV-negative 
women v. 36% among HIV-positive women (chi-square 52.6, 
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p < 0.05; odds ratio (OR) 0.20, 95% confidence interval CI: 0.12 
- 0.34)). 
The age distribution of clients in relation to Pap smear results 
is presented in Table II. Overall age distribution of Pap smear 
results is similar within each age category. Of note is that almost 
all cases of HGSILs were detected in young women co-infected 
with HIV.  
Discussion 
The high prevalence of abnormal Pap smears in young sexually 
active women co-infected with HIV utilising family planning 
services in Vulindlela, KwaZulu-Natal, is of concern. While this 
is a fairly modest, cross-sectional study, it highlights the need 
for more studies of HIV-infected populations and a re-examina-
tion of criteria being used for cervical cancer screening in high 
HIV prevalence countries where the prevalence of cervical can-
cer is also high and access to antiretroviral treatment remains 
limited.   
All the HGSILs in this study occurred in women younger 
than 30 years of age, which is much lower than the usual age 
distribution for high-grade lesions (around 35 - 40 years of 
age).  Almost all cases of HGSILs occurred among HIV-infected 
women, suggesting a strong association between HIV infection 
and cytological changes. These findings are similar to those 
of other studies6,8,9 that have demonstrated a clear association 
between HIV infection and abnormal Pap smears. Management 
of HGSILs requires immediate follow-up with colposcopy-     
directed biopsy.
Higher HIV viral loads are associated with more efficient 
HIV transmission.15-17 A substantial increase in HIV shedding 
has been observed in HIV-positive women treated for pre-can-
cerous lesions.18 Counselling and HIV risk-reduction support 
for women after treatment of the pre-cancerous lesions is im-
portant. Abstinence and/or use of male condoms during coitus 
while the cervix heals is important to reduce both the risk of 
HIV transmission and exposure to HIV.
Data from other studies19-21 on further evaluation of ASCUS 
(atypical squamous cells of unknown significance) findings 
demonstrate a cervical intra-epithelial neoplasia (CIN)-1 rate of 
10 - 20%  and a CIN-2 and CIN-3 rate of 3 - 5%. CIN-2 and CIN-
3 have a 5% risk of progression to invasive cancer.18 Hence a 
finding of ASCUS on Pap smear signifies a small but significant 
morbidity risk to the patient.   
The prevalence of LGSILs reported in this study is substan-
tially higher than the 1.6 - 2.4% reported in the literature from 
population-based surveys.22 This higher rate could reflect the 
bias of the family planning population. A 20% association 
between LGSIL and CIN2/3 has been noted in other studies.22 
Hence women with LGSIL on Pap smear screening are likely to 
have a higher probability of progressing to invasive cancer than 
women with ASCUS results. The high rate of LGSIL among 
HIV co-infected young women found in this study needs fur-
ther investigation in similar settings as the high HIV prevalence 
in this age group could be reversing the age trends of cervical 
cytological abnormalities.
Recent cervical carcinoma studies23 demonstrate a 5 - 28% 
increase in the proportion of adenocarcinoma of the cervix com-
pared with squamous cell carcinoma.  Much of this increase is 
attributed to the high incidence of adenocarcinoma of the cervix 
in women in their 20s and 30s. Hence early detection of cervical 
adenocarcinoma using ASGUS (atypical glandular cells) in the 
Pap smears is becoming increasingly important24,25 and  needs 
to be understood better in resource-constrained settings with a 
high HIV prevalence.  As the majority of the lesions detected in 
these young women, who are ordinarily not screened because 
of the age selection criteria utilised, are early precursor lesions 
for cervical cancer, they lend themselves to intervention at an 
earlier stage thus potentially reducing individual and health-
sector costs.  
Worth noting is an important quality-limiting factor when 
Pap smears are taken using the Ayre’s spatula, viz. that a lim-
Table I.  HIV serostatus and Pap smear results for family planning clients in Vulindlela, KwaZulu-Natal, 2004/2005
  HIV-positive     HIV-negative  HIV?   Total
Pap smear results  (N)    (N)   (N)   (N)
Normal    73    304   10   387
ASCUS    12      18      0      30 
LGSIL    24       17      2      43 
HGSIL      5        0      1       6 
Total  114     339    13    464
Table II. Age distribution of Pap smear clients in 
Vulindlela, KwaZulu-Natal, 2004/2005
      Age group (years) 
Pap result 0 - 29             30 - 60  Total
Normal 313                73  386 
ASCUS   23                  7    30 
LGSIL   30                12    42 
HGSIL     5                  1     6 
Total 371                93  466 
Pearson’s chi-square = 2.460, p = 0.483.
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ited number of endocervical cells are collected. It is therefore 
possible that what we have identified in this study is an under-
estimate of the true prevalence of abnormal cervical lesions in 
this population. 
The high prevalence of HIV infection in young women may 
result in high incidence of cervical epithelial pathology in this 
subgroup of women thereby creating the need for expansion of 
the overall resources allocated for the cervical cancer screening 
programme.  
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